Navigation Links
New Study Shows That Extending Prophylaxis With Clexane / Lovenox,(enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10,Days for Reducing the Risk of Venous Thromboembolism (VTE) in,Acutely ill Medical Patients With Reduced Mobility

Forward Looking Statements

This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include financial projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future events, operations, products and services, and statements regarding future performance. Forward-looking statements are generally identified by the words "expects," "anticipates," "believes," "intends," "estimates," "plans" and similar expressions. Although sanofi-aventis' management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of sanofi-aventis, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include those discussed or identified in the public filings with the SEC and the AMF made by sanofi-aventis, including those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Statements" in sanofi-aventis' annual report on Form 20-F for the year ended December 31, 2006. Other than as required by applicable law, sanofi-aventis does not undertake any obligation to update or revise any forward-looking information or statements.

    1. Samama.New England Journal of Medicine.Sept.1999.

    2. Bergqvist New England Journal of Medicine March 2002/ Vol 346, No.13.

    3. Hull, Ann Intern Med.2001; 135:858-869.

    4. Geerts.Chest.2004.

CONTACT: Contact: Philippe BARQUET +33-6-70-48-61-28

Ticker Symbol: (NYSE:SNY)

<
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
11. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
Post Your Comments:
(Date:12/4/2009)... Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) today ... the company,s Phase II-b, dose escalation, clinical trial in ... injury (TBI). Oxycyte is the Company,s perfluorocarbon (PFC) therapeutic ... in improving the outcome of patients with severe TBI. ...
(Date:12/4/2009)... Chemistry World recently highlighted a new ... of America ( PhRMA ) that identifies 97 new ... ,, The report found that the 97 products ... are either in human clinical trials or awaiting approval by ...
(Date:12/4/2009)... DIEGO, Calif., Dec. 4 Suneva Medical, a privately-held ... Philip Ranker as Vice President and Chief Financial Officer. ... Suneva Medical,s general and administrative functions including finance, accounting, ... also serve on the Company,s senior management team. ...
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4Zix Corporation CEO Provides Corporate Update for Second Quarter 2009 51001 1Zix Corporation CEO Provides Corporate Update for Second Quarter 2009 51001 2Zix Corporation CEO Provides Corporate Update for Second Quarter 2009 51001 3Zix Corporation CEO Provides Corporate Update for Second Quarter 2009 51001 4Spa Chefs Prepare You for a Healthy Summer 50996 1Spa Chefs Prepare You for a Healthy Summer 50996 2New Drug Application for Exenatide Once Weekly Accepted for Review by FDA 12927 1New Drug Application for Exenatide Once Weekly Accepted for Review by FDA 12927 2New Drug Application for Exenatide Once Weekly Accepted for Review by FDA 12927 3New Drug Application for Exenatide Once Weekly Accepted for Review by FDA 12927 4New Drug Application for Exenatide Once Weekly Accepted for Review by FDA 12927 5New Drug Application for Exenatide Once Weekly Accepted for Review by FDA 12927 6
(Date:12/5/2009)... been significant scientific advances in the field of blood ... understanding of how certain diseases progress in order to ... best care. Research presented today at the 51st Annual ... induction therapies for managing multiple myeloma, the importance of ...
(Date:12/5/2009)... steps to eliminate triggers, experts advise , , SATURDAY, Dec. ... with allergies and asthma can have bad reactions to ... to prevent sneezing and wheezing, according to the American ... who are allergic to live evergreens may choose to ...
(Date:12/5/2009)... in the most unusual places, and to do everything from growing mushrooms, ... ... 2009 -- Who would have thought that your wine, water and vegetables ... has announced a new line of turbines, for industry end users, not ...
(Date:12/4/2009)... World Assurance,Company Holdings, Ltd (NYSE: AWH ) ... and Jack Sennott, Executive Vice,President and Chief Corporate Strategy ... Financial Services Conference being held at the Goldman,Sachs Conference ... 2009. ,, About Allied World ...
(Date:12/4/2009)... 4 Pamela Bowen, Chief Information Officer at Crescent ... Innovation Officer" Appy Award for transforming Crescent,s business with ... nominated based on their innovative usage of Salesforce CRM ... customer success to their sales, marketing, partner, service, support ...
Breaking Medicine News(10 mins):Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8Health News:Keep Asthma, Allergies at Bay for the Holidays 2Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2
... to Keep Youth ... Healthy, Drug Free, NEW YORK, Oct. ... their social behavior secret from their,home life. Everyday items such as cell ... drug or alcohol,use from parents and caregivers. And according to the Partnership ...
... encourage use of designated drivers and open dialogue between parents ... ... Attorney General Steve,Carter today launched a campaign aimed at preventing drunk driving ... on stations throughout the state. The spots are timed to,coincide with the ...
... disease onset, but decline was more rapid afterward, study ... a higher level of education seems to delay the ... descent is more precipitous, a new study finds. ... which posits that people with more education have some ...
... OCTOBER 22, 2007 Late breaking results from the ... scientific symposium of the Cardiovascular Research Foundation, show that ... cardiac events (MACE) such as heart attacks, deaths from ... clear the original vessel blockage after using a Xience ...
... -- Experts dont dispute the important role that diet ... can poor eating habits and a less active lifestyle ... States today? That question has led some researchers to ... serious problem. In the October issue of Mayo Clinic ...
... and the worst off in society is closely associated with ... study published on bmj.com today as part of ... Many studies have suggested that greater income inequality in a ... focused on wealthier nations. However, it has recently been suggested ...
Other Medicine News:Health News:Don't Be 'Tricked' By Your Teen This Month - It's Time To Talk With Teens About Drug and Alcohol Use 2Health News:Don't Be 'Tricked' By Your Teen This Month - It's Time To Talk With Teens About Drug and Alcohol Use 3Health News:Don't Be 'Tricked' By Your Teen This Month - It's Time To Talk With Teens About Drug and Alcohol Use 4Health News:Indiana Attorney General Steve Carter Addresses Drunk Driving and Underage Drinking in New Radio Campaign 2Health News:Dementia in More Educated Hits Later But Harder 2Health News:Fewer adverse cardiac events at one year 2Health News:Mayo Clinic Proceedings article explores possible link between obesity and viral infections 2Health News:Mayo Clinic Proceedings article explores possible link between obesity and viral infections 3Health News:Wide income gap linked to deaths in both rich and poor nations 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: